Timmermans P B, Mathy M J, Wilffert B, Kalkman H O, Thoolen M J, de Jonge A, van Meel J C, van Zwieten P A
Naunyn Schmiedebergs Arch Pharmacol. 1983 Dec;324(4):239-45. doi: 10.1007/BF00502618.
The effects of the calcium entry blockers nifedipine, (-)-verapamil and the dihydropyridine derivative PY 108-068 were evaluated on the increase in diastolic pressure of pithed normotensive rats caused by the selective alpha 1-adrenoceptor agonists cirazoline, (-)-phenylephrine, (+/-)-erythro-methoxamine, (-)-amidephrine and St 587 [(2-chloro-5-trifluoromethylphenylimino)-2-imidazolidine] as well as by the mixed alpha 1/alpha 2-adrenoceptor agonists clonidine and DPI [(3,4-dihydroxyphenylimino)-2-imidazolidine]. The calcium entry inhibitors (up to 3 mg/kg) caused 3- to 5-fold, parallel rightward shifts of the log dose-pressor effect curves to cirazoline, (-)-phenylephrine, (+/-)-erythro-methoxamine and (-)-amidephrine accompanied by only a slight depression of the maximal pressor response. In contrast, the calcium entry inhibitors produced a dose-dependent profound depression of both maximum and slope of the log dose-pressor response curves to St 587 and clonidine. For DPI about 10- and 100-fold parallel displacements to the right without reduction of the maximum were found following treatment with 1 and 3 mg/kg of nifedipine, respectively. Infusion of vasopressin to counteract the vasodilatory action produced by the calcium entry inhibitors did not significantly change the pattern of interference observed under the conditions of decreased baseline diastolic pressure. The results indicate that alpha 1-adrenoceptor-mediated vasoconstriction in the pithed normotensive rat, which is characterized by its sensitivity to blockade by prazosin and its relative insensitivity to antagonism by yohimbine or rauwolscine, can be subdivided into two distinct processes which are differentially influenced by blockade of calcium entry.(ABSTRACT TRUNCATED AT 250 WORDS)
评估了钙通道阻滞剂硝苯地平、(-)-维拉帕米和二氢吡啶衍生物PY 108 - 068对脊髓麻醉的正常血压大鼠舒张压升高的影响,这种升高是由选择性α1肾上腺素受体激动剂可乐定、(-)-去氧肾上腺素、(±)-赤藓醇甲氧胺、(-)-酰胺福林和St 587 [(2 - 氯 - 5 - 三氟甲基苯基亚氨基)- 2 - 咪唑烷]以及混合α1/α2肾上腺素受体激动剂可乐定和DPI [(3,4 - 二羟基苯基亚氨基)- 2 - 咪唑烷]引起的。钙通道抑制剂(高达3mg/kg)使可乐定、(-)-去氧肾上腺素、(±)-赤藓醇甲氧胺和(-)-酰胺福林的对数剂量 - 升压效应曲线出现3至5倍的平行右移,同时最大升压反应仅略有降低。相比之下,钙通道抑制剂使St 587和可乐定的对数剂量 - 升压反应曲线的最大值和斜率出现剂量依赖性的显著降低。对于DPI,分别用1mg/kg和3mg/kg硝苯地平处理后,发现对数剂量 - 升压反应曲线分别向右平行移动约10倍和100倍,且最大值未降低。输注血管加压素以抵消钙通道抑制剂产生的血管舒张作用,在基线舒张压降低的情况下,并未显著改变所观察到的干扰模式。结果表明,脊髓麻醉的正常血压大鼠中由α1肾上腺素受体介导的血管收缩,其特征为对哌唑嗪阻断敏感且对育亨宾或萝芙木碱拮抗相对不敏感,可分为两个不同的过程,它们受钙通道阻断的影响不同。(摘要截短于250字)